Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic

Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic

US Patent 6740669 · Granted May 25, 2004

Estimated economic value: $6,413,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl es2025
Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid2024
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester2024
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl este2024
Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxye2023
Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid2022
Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid2021
Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organ2021
Solid form of abiraterone acetate2018
Salts of dasatinib in amorphous form2018
Multicomponent crystalline system comprising nilotinib and selected co-crystal f2017